PRA Health Sciences Inc

PRA Health Sciences — Q1 2015 Earnings Presentation

14 slides from PRA Health Sciences's earnings presentation, May 6, 2015

  1. Slide 1: Q1 2015 Earnings

    Q1 2015 Earnings May 6, 2015 PRAHEALTHSCIENCES

  2. Slide 2: Forward Looking Statements and Use of Non-GAAP Financial Measures

    Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements that reflect, among other things, the Company’s current expectations and anticipated results of operations, all of which are subject to known and unknown risks, uncertainties and o

  3. Slide 3: Financial Overview

    x Financial Overview PRAHEALTHSCIENCES

  4. Slide 4: Q1 2015 Financial Results

    Q1 2015 Financial Results ($ in millions) Q1 2015 Q1 2014 % Change Service Revenue 332.0 $ 311.4 $ 6.6% EBITDA 59.8 $ 30.0 $ 99.3% Adjusted EBITDA 55.7 $ 39.7 $ 40.3% Adjusted EBITDA Margin 16.8% 12.7% Operating Income 32.9 $ 10.7 $ 207.5% Adjusted Operating Income 50.6 $ 33.8 $ 49.7% Adjusted Opera

  5. Slide 5: Trailing Quarterly Performance

    Trailing Quarterly Performance Q1 15 v ($ in millions) Q1 14 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Change Service revenue 166.5 $ 179.5 $ 188.1 $ 298.8 $ 832.9 $ 311.4 $ 311.3 $ 320.1 $ 323.8 $ 1,266.6 $ 332.0 $ 6.6% % growth Y-o-Y 13.0% 22.2% 27.9% 91.7% 39.5% 87.0% 73.4% 70.2% 8.4% 52.1% 6.6% % growt

  6. Slide 6: Backlog and New Business Awards

    Backlog and New Business Awards Q1 15 v ($ in millions) Q1 14 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Change Beginning Backlog 1,382.8 $ 1,421.2 $ 1,444.2 $ 1,465.6 $ 1,382.8 $ 1,939.7 $ 1,987.3 $ 2,044.8 $ 2,091.5 $ 1,939.7 $ 2,141.1 $ Ending Backlog 1,421.2 $ 1,444.2 $ 1,465.6 $ 1,939.7 $ 1,939.7 $ 1,9

  7. Slide 7: Debt Structure

    Debt Structure Weighted Average ($ in millions) March 31, June 30, September 30, December 31, March 31, Interest Maturity 2014 2014 2014 2014 2015 Rate Date Senior debt: First Lien 885.6 $ 883.3 $ 881.1 $ 729.0 $ 714.0 $ 4.50% September 23, 2020 Senior Notes 375.0 375.0 375.0 225.0 225.0 9.50% Octob

  8. Slide 8: Reconciliation of GAAP EBITDA to Adjusted EBITDA

    Reconciliation of GAAP EBITDA to Adjusted EBITDA For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2015 2014 Net income (loss) 17.2 $ (10.0) $ Depreciation and amortization 19.2 24.6 Interest

  9. Slide 9: Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income

    Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions, except per share data) 2015 2014 Net income (loss) 17.2 $ (10.0) $ Amortizatio

  10. Slide 10: Reconciliation of GAAP Income from Operations to Adjusted Income from Operations

    Reconciliation of GAAP Income from Operations to Adjusted Income from Operations For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2015 2014 Income from operations 32.9 $ 10.7 $ Amortization o

  11. Slide 11: Appendix

    Appendix PRAHEALTHSCIENCES

  12. Slide 12: Geographic Breakdown

    Geographic Breakdown Region Q1 15 Q1 14 US/Canada 201,969 182,096 Europe/Africa 101,010 103,071 Latin America 13,446 13,904 Asia/Pacific 15,543 12,281 Grand Total 331,968 311,352

  13. Slide 13: Days Sales Outstanding

    Days Sales Outstanding ($ in millions) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Accounts Receivable, net 136.9 $ 157.4 $ 141.2 $ 232.6 $ 246.0 $ 241.9 $ 236.1 $ 233.3 $ 239.6 $ Unbilled Services 63.1 56.2 58.3 62.3 102.3 98.0 113.2 105.5 132.8 Total Accounts Receivable and Unbilled Services 200.0 213.6 199.5 294.

  14. Slide 14: PRAHEALTHSCIENCES

    m\/A Ws PRAHEALTHSCIENCES HE FU RE OF CLINICAL DEVELOPME

PRA Health Sciences — Q1 2015 Earnings Presentation on 6ix